Related references
Note: Only part of the references are listed.New insights into the mechanism of antifungal action of 8-hydroxyquinolines
Bruna Pippi et al.
SAUDI PHARMACEUTICAL JOURNAL (2019)
In vitro susceptibility of Microsporum spp. and mammalian cells to Eugenia caryophyllus essential oil, eugenol and semisynthetic derivatives
Sandra Milena Leal Pinto et al.
MYCOSES (2019)
Antifungals discovery: an insight into new strategies to combat antifungal resistance
A. M. Fuentefria et al.
LETTERS IN APPLIED MICROBIOLOGY (2018)
Mutation in the Squalene Epoxidase Gene of Trichophyton interdigitale and Trichophyton rubrum Associated with Allylamine Resistance
Shivaprakash M. Rudramurthy et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Antifungal drug susceptibility profile of clinically important dermatophytes and determination of point mutations in terbinafine-resistant isolates
Zahra Salehi et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2018)
Antifungal mechanism of action of Schinus lentiscifolius Marchand essential oil and its synergistic effect in vitro with terbinafine and ciclopirox against dermatophytes
Leticia J. Danielli et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2018)
In Vitro additive effect on griseofulvin and terbinafine combinations against multidrug-resistant dermatophytes
Aline Jacobi Dalla Lana et al.
BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
Toward a Novel Multilocus Phylogenetic Taxonomy for the Dermatophytes
G. Sybren de Hoog et al.
MYCOPATHOLOGIA (2017)
Synergistic effects of some essential oils against fungal spoilage on pear fruit
Mehdi Nikkhah et al.
INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY (2017)
Evaluation of 8-Hydroxyquinoline Derivatives as Hits for Antifungal Drug Design
Bruna Pippi et al.
MEDICAL MYCOLOGY (2017)
Diagnosis and treatment of dermatophytosis in dogs and cats. Clinical Consensus Guidelines of the World Association for Veterinary Dermatology
Karen A. Moriello et al.
VETERINARY DERMATOLOGY (2017)
8-Hydroxyquinolines in medicinal chemistry: A structural perspective
Valentina Oliveri et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Using combination therapy to thwart drug resistance
Jessica A. Hill et al.
FUTURE MICROBIOLOGY (2015)
A combination approach to treating fungal infections
Sanjib K. Shrestha et al.
SCIENTIFIC REPORTS (2015)
Three Dimensional Checkerboard Synergy Analysis of Colistin, Meropenem, Tigecycline against Multidrug-Resistant Clinical Klebsiella pneumonia Isolates
Claudia Stein et al.
PLOS ONE (2015)
Clinical, epidemiological, and therapeutic profile of dermatophytosis
Carla Andrea Avelar Pires et al.
ANAIS BRASILEIROS DE DERMATOLOGIA (2014)
Antifungal Combination Therapy for Invasive Aspergillosis
Almudena Martin-Pena et al.
CLINICAL INFECTIOUS DISEASES (2014)
Fungi on the Skin: Dermatophytes and Malassezia
Theodore C. White et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2014)
In Vitro Antifungal Activity of Naftifine Hydrochloride against Dermatophytes
M. Ghannoum et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Therapies for the treatment of onychomycosis
Aditya K. Gupta et al.
CLINICS IN DERMATOLOGY (2013)
Combination antifungal therapy for invasive fungal infections in children and adults
Nevin Hatipoglu et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2013)
Dermatophytes: host-pathogen interaction and antifungal resistance
Nalu Teixera de Aguiar Peres et al.
ANAIS BRASILEIROS DE DERMATOLOGIA (2010)
Ciclopirox Recent Nonclinical and Clinical Data Relevant to its Use as a Topical Antimycotic Agent
Alessandro Subissi et al.
DRUGS (2010)
Topical delivery of antifungal agents
Indu Pal Kaur et al.
EXPERT OPINION ON DRUG DELIVERY (2010)
Clinical Forms of Dermatophytosis (Ringworm Infection)
Hugo Degreef
MYCOPATHOLOGIA (2008)
Antifungal interactions within the triple combination of amphotericin B, caspofungin and voriconazole against Aspergillus species
Elizabeth M. O'Shaughnessy et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Antifungal combination therapy - Clinical potential
JW Baddley et al.
DRUGS (2005)
Combination antifungal therapy
MD Johnson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
In vitro evaluation of double and triple combinations of antifungal drugs against Aspergillus fumigatus and Aspergillus terreus
E Dannaoui et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Onychomycosis in clinical practice: factors contributing to recurrence
RK Scher et al.
BRITISH JOURNAL OF DERMATOLOGY (2003)
Drug synergies and the potential for combination therapy in onychomycosis
EGV Evans
BRITISH JOURNAL OF DERMATOLOGY (2003)
Caspofungin in combination with itraconazole and amphotericin B for the treatment of invasive aspergillosis in humans, with a method to test ex vivo synergism
C Tascini et al.
CLINICAL MICROBIOLOGY AND INFECTION (2003)
In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity
AK Gupta et al.
BRITISH JOURNAL OF DERMATOLOGY (2003)
Share Paper
